Price range: $195.00 through $381.00
Catalog Number: 32005-05141
Purified antibody validated for specificity and sensitivity.
| Format | IgG-FITC Conjugate |
|---|---|
| Entrez Gene | 216 |
| Associated Disease | Metabolism |
| Species | Human |
| UniProt | P00352 |
| Size | Full Size, Trial Size |
| Purity | Affinity Purified |
| Presentation | 0.02% Sodium Azide, 20 mg/ml BSA, and 4% Trehalose, Lyophilized from PBS pH 7.4 |
| Host | Rabbit |
| Storage | 2-8°C, Do Not Freeze |
| Application | FACS, ICC, IF, IHC |
| Immunogen | Human Aldehyde dehydrogenase 1A1 (1-501 aa) expressed in E. coli |
| Label | FITC conjugated |
Everolimus combined with 5-aza-2-deoxycytidine generated potent anti-tumor effects on ovarian clear cell cancer stem-like/spheroid cells by inhibiting the COL6A3 …
Derivation of Human Corneal Keratocytes from ReLEx SMILE Lenticules for Cell Therapy and Tissue Engineering
Everolimus combined with 5-aza-2-deoxycytidine generated potent anti-tumor effects on ovarian clear cell cancer stem-like/spheroid cells by inhibiting the COL6A3-AKT-mTOR pathway
* Surovtseva MA et al. (2023) Derivation of Human Corneal Keratocytes from ReLEx SMILE Lenticules for Cell Therapy and Tissue Engineering. Int J Mol Sci. 24(10):8828.
* Ho CM et al. (2022) Everolimus combined with 5-aza-2-deoxycytidine generated potent anti-tumor effects on ovarian clear cell cancer stem-like/spheroid cells by inhibiting the COL6A3-AKT-mTOR pathway. Am J Cancer Res. 12(4):1686-1706.
Loading data...
